Use of antiviral drugs to reduce COVID-19 transmission
Lancet Glob Health
.
2020 May;8(5):e639-e640.
doi: 10.1016/S2214-109X(20)30114-5.
Epub 2020 Mar 19.
Authors
Oriol Mitjà
1
,
Bonaventura Clotet
2
Affiliations
1
Infectious Diseases Department-Fight AIDS Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Electronic address: omitja@flsida.org.
2
Infectious Diseases Department-Fight AIDS Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; IrsiCaixa Foundation, Barcelona, Spain.
PMID:
32199468
PMCID:
PMC7104000
DOI:
10.1016/S2214-109X(20)30114-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents*
Betacoronavirus
COVID-19
Coronavirus Infections
Disease Outbreaks
Feasibility Studies
Pandemics
Pneumonia, Viral
SARS-CoV-2
Substances
Antiviral Agents